Fourth-generation ‘pod’ e-cigarette devices have been driven by technological advances in electronic atomization of the e-liquid. Use of microporous ceramic as a wicking material improves heating efficiency, but how it affects the chemical emissions of these devices is unclear. We assessed the emissions of a pod e-cigarette with innovative ceramic wick-based technology and two flavoured e-liquids containing nicotine lactate and nicotine benzoate (57 and 18 mg mL−1 nicotine, respectively). Among the studied harmful and potentially harmful constituents (HPHCs) listed by the US FDA and/or WHO TobReg, only 5 (acetone, acetaldehyde, formaldehyde, naphthalene and nornicotine) were quantified at levels of 0.14 to 100 ng puff−1. In the combustible cigarette (Kentucky reference 1R6F), levels were from 0.131 to 168 µg puff−1. Nicotine levels ranged 0.10–0.32 mg puff−1 across the 3 study products. From the 19 proposed HPHCs specifically of concern in e-cigarettes, only 3 (glycerol, isoamyl acetate and propylene glycol) were quantified. The low/undetectable levels of HPHCs reflect not only the optimal operating conditions of the e-cigarette, including an efficient supply of e-liquid by the ceramic wick without overheating, but also the potential of the e-cigarettes to be used as an alternative to combustible cigarettes.
E-cigarettes are battery-powered devices designed to deliver nicotine and/or other substances including, in some cases, flavourings. Although e-cigarettes were first proposed in 1927 by Joseph Robinson1, it was only in the early 2000s that the 1st generation of e-cigarettes or ‘cig-a-likes’ became commercially available2,3,4. Subsequent generations of devices have evolved since then, ranging from e-cigarettes with prefilled or refillable cartridges (2nd generation) to rechargeable tank-style devices (3rd generation) with modifiable or ‘‘Mods’’ components3,4,5,6. The 4th generation of devices, known as ‘Pods’, has been driven by advances in electronic atomization technology3,7,8,9.
E-cigarettes consist of a mouthpiece, an e-liquid chamber, an atomiser and a battery. The atomiser has a wicking material that draws the e-liquid onto a battery-powered heating coil. Optimal vapour production depends on an efficient supply of e-liquid to the heating coil, which is limited by the wicking and rate of e-liquid evaporation10,11,12. Power levels that produce aerosol beyond the ability of the wick to resupply the liquid to the coil may result in overheating of the atomizer coil and consequently overheating of the e-liquid10,11. Different types of wicking material, varying in size and shape, have been used in e-cigarettes3,13. Silica was commonly the first material to be used as a wick, followed by cotton and ceramic3,13,14,15. Cotton has good wicking properties but is less thermally stable than silica14,16,17, while ceramic is chemically stable and heat-resistant18. The use of microporous ceramic as a wicking material has increased in the past few years14,16,18,19,20. Its application has been reported to improve heating efficiency and reduce charring14,16,18,19,20.
E-liquids are an important part of any vaping system and their composition, together with the characteristics of the device, may have an impact on nicotine delivery21. They mainly constitute a mix of propylene glycol (PG), glycerol (vegetable glycerine or VG) and nicotine. E-liquids may include flavouring compounds and usually come in different nicotine strengths or concentrations.
To help adult users to completely switch to alternative nicotine products, it is important the other alternatives provide effective nicotine delivery comparable or close to that of conventional/combustibles cigarettes22,23. Heavy smokers (12.4 ± 8.4 cigarettes per day, n = 11) have found that e-cigarettes, especially those from the 1st generation, were unsatisfactory because delivery of nicotine was ineffective as compared with conventional cigarettes22. Later generations of devices have achieved improved nicotine delivery by using different product designs and power settings, innovative materials, and nicotine salts in e-cigarette formulations3,21,22,24,25. For example, Bowen and Xing24 reported that a combination of nicotine with some weak organic acids, such as benzoic, lauric, levulinic, salicylic or sorbic acid, provides satisfaction comparable to that of conventional cigarettes. They suggested that the satisfaction effect was consistent with an efficient transfer of nicotine to the user’s lungs and a rapid rise in nicotine absorption in the plasma24. Use of lactic acid and pyruvic acid has been investigated by other authors, who reported nicotine absorption kinetics that are similar to those of conventional cigarettes and associated with acceptable sensory qualities and relief of craving23,25,26,27. A combination of nicotine with weak organic acids to form nicotine salts has also been applied in pharmaceutical formulations used in Metered Dose Inhalers (MDIs) therapy equipment28. Its application in e-cigarette formulations has the potential to mimic cigarette smoking’s nicotine pharmacokinetics, which may help cigarette smokers to transition to e-cigarettes22,23,25,26,27,29,30,31,32.
E-cigarettes do not burn tobacco and may produce less harmful and potentially harmful constituents (HPHCs) as compared with combustible cigarettes6,33,34,35,36,37. HPHCs have been defined by the US Food and Drug Administration (U.S FDA) as chemicals or chemical compounds in tobacco products or tobacco smoke that cause or might cause harm to smokers or non-smokers38,39. E-cigarettes have been recognised as an alternative for adult smokers who are unable or unwilling to quit smoking35,37,40,41,42,43,44,45,46. The most recent Public Health England evidence review highlights, as a key finding, a study suggesting that the cancer potencies of e-cigarettes were largely less than 0.5% of those of smoking42. The risks of cardiovascular disease and lung disease have not been quantified for e-cigarettes, but are also likely to be substantially less than those from smoking42. Because e-cigarettes do not burn tobacco, the reduction of harmful substances depends on the chemical composition of the e-liquid, as well as the characteristics of the device4,5,15,47,48,49. For example: overheating of e-liquid on the coil and poor wicking performance may lead to an increase in carbonyls to levels higher than observed in cigarette smoke11,15,47,50,51.
Compared with silica and cotton wicking materials, there are fewer studies on ceramic wick-based e-cigarette systems, and their impact on e-cigarettes emissions is less documented in the literature. To address this gap, the aim of this study was to characterise the vapour emitted by a 4th-generation pod e-cigarette designed with a ceramic wick-based technology using ISO 20768:2018 standard puffing regime (55 mL puff volume/3 s puff duration/30 s puff frequency; rectangular puff profile)52. The emissions of two Berry Blast flavoured e-liquids with different levels of nicotine and different nicotine salts (BB57 with 57 mg mL–1 of nicotine containing lactic acid and BB18 with 18 mg mL–1 of nicotine containing benzoic acid) were tested for a total of 89 organic compounds covering different classes of compounds (e.g., nicotine and non-nicotine toxicants). From those, 55 compounds have been listed by the U.S. FDA as relevant to tobacco products and with 19 compounds proposed by the FDA as HPHCs of specific concern in e-cigarette aerosols38,39,44,53,54. We also focused on the nine toxicants (acetaldehyde, acrolein, benzo[a]pyrene, benzene, 1,3-butadiene, carbon monoxide (CO), formaldehyde, nitrosonornicotine (NNN) and 4-(N-nitrosomethylamino)-1-(3-pyridyl)-1-butanone (NNK) recommended for mandated reduction in cigarette smoke by the WHO Tobacco Product Regulation Group (WHO TobReg) which are also part of the HPHCs U.S.FDA list53,54,55. To provide context, e-cigarette vapour emissions were compared with smoke yields from a reference cigarette (Kentucky 1R6F (Ky1R6F)) smoked under ISO 20778:2018 puffing regime (55 mL puff volume/2 s puff duration/30 s puff frequency; bell-shaped puff profile, 100% ventilation blocked)56,57.
Results and discussion
Carbon monoxide, aerosol mass and water
Table 1 summarizes the per-puff levels of CO, aerosol collected mass (ACM), water and nicotine in the emissions from two e-cigarettes: namely, Berry Blast 57 mg mL−1 of nicotine containing lactic acid (BB57); and Berry Blast 18 mg mL−1 of nicotine containing benzoic acid (BB18). CO, which is associated with combustion of organic material, was below the limit of detection (< LOD) for both e-cigarettes, with a percentage reduction of 99.8% relative to Ky1R6F cigarette smoke (Table 1). ACM, which comprises mainly PG, VG, water, nicotine and other minor constituents, was in the same range for both e-cigarettes. ACM results were found to be reproducible across all methods as demonstrated by the low standard deviation of ACM in both e-cigarette emissions (6.58 ± 0.39 mg puff−1 and 6.46 ± 0.36 mg puff−1 for BB57 and BB18 respectively), accounting for a coefficient of variation of 5.9% and 5.5% for BB57 and BB18, respectively (n = 85). This is an indication of sampling robustness and puffing consistency. The nicotine-free dry particulate matter (NFDPM) or ‘tar’, a parameter associated with cigarette smoke, consists predominantly of combustion by-products36,58. The level of NFDPM, 3.67 ± 0.30 mg puff−1 equivalent to 33 ± 3 mg cig−1, was in accordance with the Ky1R6F certified value of 29 ± 2 mg cig−1 (ISO Intense smoking regime)56.
Humectants and related impurities
In terms of humectants, levels of PG and VG were higher in the e-cigarette emissions than in the Ky1R6F cigarette smoke (Table 1). Because PG and VG are the main constituents of e-liquids, these results were expected. Diethylene glycol (DEG) and ethylene glycol (EG), which may be present in e-liquids as impurities59,60, were < LOD in the e-cigarette emissions. These compounds were raised as a potential concern by the U.S FDA after reports of their detection in e-liquids53,54,61. EG is widely used as an anti-freeze agent and is associated with pronounced toxicological risks50. The US Pharmacopeia (USP) has set a limit for DEG and EG of 0.1% (1 mg g–1) in both PG and VG59,60,62. Their low levels in the e-cigarette emissions shows the importance of using pharmaceutical-grade PG and VG. Glycidol, which is listed as a probable carcinogen by the International Agency for Research on Cancer (IARC)63, was < LOD for both e-cigarette emissions and cigarette smoke.
Nicotine, nicotine-related impurities and TSNAs
As shown in Table 1, different nicotine concentrations were observed for the e-cigarette emissions and Ky1R6F cigarette smoke, with nicotine levels in cigarette smoke (0.23 mg puff–1) lying between those in the two e-cigarette emissions (BB18, 0.10 mg puff–1; BB57, 0.32 mg puff–1). The concentration of nicotine in the BB57 emissions relative to BB18 was three times greater and followed the three-fold increase in nicotine strength of the e-liquid. In the cigarette smoke, the measured nicotine concentration of 0.23 ± 0.01 mg puff–1 (Table 1), equivalent to 2.07 ± 0.09 mg cig−1, is in accordance with the Ky1R6F certificate value of 1.9 ± 0.1 mg cig−1 (ISO Intense smoking regime)56. Nicotine yields for different e-cigarette brands have been reported from 2 to 313 µg puff−1 while for conventional cigarettes smoke the values ranged from 170 to 232 µg puff−16,31,36,48,64.
Nicotine-related impurities were present mainly in cigarette smoke at a significantly higher level than in e-cigarette emissions (note that the percentage reduction of anabasine and nicotine-N-oxide was not calculated because these impurities were < LOD in cigarette smoke and the e-cigarette emissions). In general, the nicotine used in e-liquids is extracted from tobacco and may contain other minor related alkaloids as impurities64,65. Therefore, nicotine-related impurities might be expected in e-cigarettes emissions and are considered acceptable by the USP and European Pharmacopeia in standard nicotine used in e-liquids6,66,67,68. The USP requires single impurities to be less than 0.5% (5 mg g–1) of nicotine, and total impurities to be less than 1% (10 mg g–1)66. The European Pharmacopeia requires each of seven specified impurities (anabasine, anatabine, cotinine, myosmine, nicotine-N-oxide, β-nicotyrine, nornicotine; Table 1) to be below 0.3%, unspecified impurities to be no more than 0.1% each, and total impurities to be less than 0.8% of nicotine content6,66,67,68. In our study, all analysed nicotine-related impurities in the e-cigarette emissions were below the levels stated by the USP and European Pharmacopeia for e-liquids (Table 1). This is consistent with the fact that only nicotine of pharmaceutical-grade is used in the production of these e-liquids. β-Nicotyrine, a pyrolysis product of nicotine69, was present at the highest level in cigarette smoke (0.42 µg puff–1). The observed reduction of 98% per puff in the emissions of both e-liquids is a good indication that the heat generated in the device atomiser is not sufficient to thermally breakdown nicotine to β-nicotyrine.
Another class of nicotine-related HPHCs of concern are tobacco-specific nitrosamines (TSNAs): namely, NNN, NNK, nitrosoanabasine and nitrosoanatabine. These non-volatile compounds may be present in e-liquids as impurities from tobacco nicotine extraction and are important compounds associated with negative health effects of cigarette smoke34,70,71,72,73,74. Two of the reported TSNAs, namely NNN and NNK, are classified as carcinogens and included in U.S FDA’s HPHC lists that apply to cigarette smoke and electronic nicotine delivery systems (ENDS)39,53,75. NNN and NNK are also included in the nine WHO TobReg priority smoke toxicants55. In our study, the levels of all four TSNAs were < LOD for both e-cigarette emissions with a percentage reduction of ≥ 99.9% as compared with cigarette smoke (Table 1).
Polycyclic aromatic compounds
Another class of chemicals in cigarette smoke that poses health concerns are polycyclic aromatic hydrocarbons (PAHs), which are compounds with two or more fused benzenoid rings that are known for their carcinogenic and mutagenic properties76. The levels of PAHs in e-cigarette emissions were either < LOD or < LOQ (chrysene), except for naphthalene and pyrene (Table 2). Notably, these two compounds were higher than the limit of quantification (LOQ) in the method air blanks. Pyrene was in the same concentration in e-cigarettes as in the method air blank (0.1 ng puff–1). PAHs are present in the atmosphere as components of various dusts, tars, oils and engine exhaust gases72. The presence of pyrene in the e-cigarette aerosol is therefore most probably an artefact due to environmental contamination, as indicated by the method air blank.
Levels of naphthalene were slightly higher than those of pyrene in e-cigarette emissions, while the respective air blank was lower. Nevertheless, it seems likely that these compounds were detected in e-cigarette emissions due to their presence as low-level contaminants in the background air, rather than originating from the vaping product. In terms of the levels detected, even if we assume a worst-case exposure of 300 puffs per day based on the million puff study (which reported a median use of 130 puffs day–1 and where 85% of users did not exceed 300 puffs day–177), a consumer’s daily exposure to each of these compounds would be less than 0.15 µg day–1, the toxicological threshold of concern for mutagenic compounds78,79. Furthermore, most PAHs, including naphthalene and pyrene, showed a percentage reduction in e-cigarette emissions of ≥ 99% versus Ky1R6F cigarette smoke, while indenol[1,2,3-cd]pyrene showed a reduction of 92.5% because it was also present at only low levels in cigarette smoke (0.02 ng puff–1).
Collectively, our findings are consistent with the knowledge that PAHs are primarily products of combustion. For PAHs present at very high concentrations in cigarette smoke, such as benzo[a]pyrene, chrysene and pyrene, the percentage reduction in e-cigarette emissions was > 99%. In particular, benzo[a]pyrene, which is included in the nine WHO TobReg priority smoke toxicants, was reduced by 99.7% in e-cigarette emissions as compared with the smoke from the reference cigarette.
Phenolic compounds and carbonyls
In cigarette smoke, the phenols of concern are catechol, m-cresol, p-cresol, o-cresol, hydroquinone, phenol and resorcinol (Table 3). They can be formed by the thermal degradation of tobacco leaf constituents such as lignin and chlorogenic acid71,72,80,81. Temperature is an important factor in the formation of phenolic compounds. Studies have reported that catechol and hydroquinone are formed in cigarette smoke at low temperatures (< 350 °C), while cresol, phenol and resorcinol are formed at temperatures of 350–600 °C81. In e-liquids, phenols and their precursors may be present as impurities derived from nicotine and may be transferred to the aerosol and inhaled by the vaper71,72. Phenols may also be formed upon vaporisation. Phenol emissions have been found to be independent of the nicotine benzoate concentration but significantly correlated with the PG/VG ratio. Emissions increased with power and puff duration, consistent with conditions that lead to a higher temperature and greater thermal degradation82. In our study, the levels of all seven phenols were < LOD in both e-cigarette emissions with a percentage reduction of ≥ 99% versus cigarette smoke (Table 3). The low operating temperatures of the e-cigarette device studied herein and the use of pharmaceutical- and food-grade ingredients in the e-liquids considerably reduce the likely presence of these phenolic compounds in e-cigarette aerosol.
Carbonyls in cigarette smoke are formed mainly by pyrolysis of tobacco sugars83, whereas those in e-cigarettes are formed mainly by thermal degradation of PG and/or VG83,84,85. Flavourings may also contribute to the formation of carbonyls, as well as the characteristics of the e-cigarette devices, especially the applied voltage, coil resistance and wicking material47,48,49,86,87. Poor wicking efficiency may lead to a dry wick and overheated e-liquid (dry puff), which promotes the formation of carbonyls and other toxic compounds2,10,13,15. Coil location, orientation, resistance and wick material, as well as power output, have been shown to affect carbonyl generation significantly13,15,86. E-liquid physical properties are also important in carbonyl formation15,47,84,86. The viscosity and density of the e-liquid determine its mobility, capillary action, and delivery to the wick and coil, influencing the likelihood of a dry puff15.
Several studies have reported the presence of carbonyls in e-cigarette emissions at levels ranging from 0.07 to 413 µg puff–185,88,89. In our study, among the 14 analysed carbonyls (aldehydes and ketones), only five were quantifiable (acetaldehyde, acetone, formaldehyde, glyoxal and methylglyoxal) in the e-cigarette emissions at concentrations ranging from 0.02 to 0.19 µg puff–1 (Table 3). Of these, acetone was detected at the same level in e-cigarette emissions as the method air blank (0.04 µg puff–1). Detectable air blank values may arise from environmental contamination6,9,34,90. Acetaldehyde was quantified in BB57 emissions (0.10 µg puff–1) but was < LOQ in BB18 emissions, while formaldehyde was present in both (BB57, 0.04 µg puff–1; BB18, 0.07 µg puff–1). However, these two carbonyls were below the target levels proposed in the experimental voluntary standard published by the Association Française de Normalization (AFNOR; 16 µg puff–1 for acetaldehyde and 1 µg puff–1 for formaldehyde)91. Previous data indicate that the higher the percentage ratio of VG to PG, the higher the concentrations of carbonyl compounds emitted, especially acetaldehyde, acrolein and acetone84. In our study, both e-liquids had equivalent amounts of VG and PG; therefore, this ratio is likely to be irrelevant to the different concentrations of carbonyls detected in the two e-cigarette emissions, especially acetaldehyde. In a previous study, higher levels of acetaldehyde, acrolein and formaldehyde were generated in the emissions from an e-liquid without nicotine than in those from an e-liquid with nicotine; however, the observed carbonyl concentrations were strictly related to both the composition of the liquids and also the coil resistance47. In the presence of nicotine, the content of carbonyls, especially formaldehyde, was significantly higher with a 1.50-Ω coil than with a 0.25-Ω coil47. In our study, only acetaldehyde increased with the higher nicotine product (BB57); however, its concentration (0.10 µg puff–1) was still 160 times lower than the maximum level proposed by AFNOR (16 µg puff–1)91. A comparison of the emissions of an e-liquid with similar PG/VG ratio (1:1) emitted by a relatively similar Vype device (ePen) that uses a silica wick showed that formaldehyde at a concentration of 0.59 µg puff–1 was 8× higher and acetaldehyde at a concentration of 0.18 µg puff–1 was 2× higher than in the emissions presented herein (Table 3)92. In both studies, the values were below the maximum level proposed by AFNOR91.
From the studied carbonyls, only acetaldehyde, acrolein and formaldehyde are included in the nine WHO TobReg priority smoke toxicants55. Relative to cigarette smoke, their percentage of reduction in the e-cigarette emissions was ≥ 98.8%.
Among the 14 studied carbonyls, 7 were included in the new U.S. FDA HPHCs list for e-cigarettes53,54; namely, acetaldehyde, acrolein, formaldehyde and butyraldehyde, crotonaldehyde, and the diketones; diacetyl (2,3-butanedione) and acetyl propionyl (2,3-pentanedione). In the e-cigarette emissions, butyraldehyde and crotonaldehyde and acetyl propionyl were < LOD while acrolein and diacetyl were < LOQ. Acetoin, a precursor of diacetyl and acetyl propionyl, was also < LOD93.
Glyoxal and methylglyoxal are formed by thermal degradation or oxidation of PG and VG87. Glyoxal is considered mutagenic, while the related compound methylglyoxal has been identified as a metabolite during glycolysis and is thus naturally present in the body. Methylglyoxal is also present in foods and drinks such as honey and coffee. A lack of data has led to classification of methylgloxal as a Group 3 carcinogen (carcinogenicity to humans not classifiable) by IARC. Both compounds have been previously detected in e-cigarette emissions at concentrations of 0.07–0.94 and 0.09–33 µg puff–1, respectively86,88. In our study, glyoxal was present at lower levels (BB57 and BB18, 0.02 and 0.05 µg puff–1, respectively), while methylglyoxal was at concentrations of 0.13 and 0.19 µg puff–1 in BB57 and BB18, respectively (Table 3). Glyoxal was detected in the method air blank and therefore the actual levels in the e-cigarette emissions are potentially lower than reported in Table 3. Again assuming a worst-case exposure of 300 puffs day–1 spread over 8 h, the levels of glyoxal exposure to a consumer would still be more than 40 times lower than the occupational exposure limit of 0.10 mg m–377,94,95. The high standard deviation for glyoxal and methylglyoxal observed in BB18 e-cigarette emissions is probably related to an analytical sample matrix effect and/or batch variability83,96,97. Despite the high standard deviation, the percentage reduction of glyoxal and methylglyoxal in both e-cigarette emissions relative to cigarette smoke was ≥ 97.0% and ≥ 94.5%, respectively (Table 3).
In our analysis, levels of carbonyls were considerably reduced relative both to other studies of e-cigarettes and to Ky1R6F cigarette smoke. Levels below the LOD or LOQ, or even below the threshold levels proposed by the AFNOR standard guidelines, provide evidence of the optimal operation conditions (e.g., adequate wick saturation without extreme coil heating) of the ceramic wick-based device.
Volatile organic compounds
Table 4 summarizes the levels of volatile organic compounds (VOCs) in the e-cigarette emissions and Ky1R6F cigarette smoke, along with the percentage reductions. Among the 23 VOCs analysed, levels were < LOD for both e-cigarette emissions, except for hydrogen cyanide (BB57, < LOQ), allyl alcohol (both < LOQ) and acetamide (BB57, < LOQ). Four of the VOCs, namely, acrylonitrile, benzene, propylene oxide and toluene, are listed by the U.S. FDA as compounds of concern for e-cigarettes53, while benzene and 1,3-butadiene are included in the nine WHO TobReg priority smoke toxicants55. The level of all of these compounds was < LOD with percentage reductions of ≥ 99.0% relative to Ky1R6F smoke (Table 4).
In particular, benzene, which may be formed by decarboxylation of benzoic acid, was undetectable in both e-cigarette emissions. Pankow et al.98 previously reported that benzene concentrations were largely undetectable for an e-cigarette with a single vertical coil and a cotton wick, but were more readily detected for a device with a single horizontal coil and a silica wick. Their results demonstrated the importance of the orientation of the coil and the type of wicking material in the formation of benzene. Our results showed that neither use of benzoic acid in the BB18 formulation nor the characteristics or operating conditions of the device contributed to benzene formation in the e-cigarette emissions. Pankow et al.98 also reported that benzene may be formed by the dehydration and cyclization of PG and VG, especially at high-power settings using a tank system with a single horizontal coil and a silica wick. Other studies have shown that 1,3-butadiene may be formed by VG degradation and is an important intermediate in the formation of benzene from VG84,98. Aromatic VOCs such as toluene, xylene, styrene and ethylbenzene may also be formed by thermal degradation of VG, where benzene plays an important role as an intermediate84. Benzene and other combustion-related compounds including acrylonitrile, isoprene and toluene may also be present in e-cigarette emissions as impurities of nicotine34. Percentage transfers to aerosol of ≥ 89% have been reported for these compounds after fortification of e-liquids at high levels (46–232 ng g–1)34. Other combustion-related compounds such as allyl alcohol and propylene oxide have been detected in e-cigarette emissions as thermal degradation products of PG and/or VG49,99. In our study, all these compounds were < LOD or < LOQ.
The above-cited studies show that the chemical composition of the e-liquid, the design of the device, and the temperature at which the e-liquids vaporize have a strong impact on the formation of VOCs and their transfer to e-cigarette emissions, especially those that originate primarily from heating of PG and VG. Our findings of levels < LOD or < LOQ in the e-cigarette emissions for the studied VOCs indicate the consistent supply of e-liquid by the ceramic wick without overheating of the coil and, consequently, overheating of the e-liquid. There was no considerable difference in levels of VOCs in the two emissions produced from e-liquids with different types of nicotine salt and different nicotine strengths. Moreover, there was a considerable reduction of VOCs in both e-cigarette emissions relative to cigarette smoke.
Flavouring compounds and acids
Next, we examined the e-cigarette emissions of flavouring compounds, together with acetic acid and propionic acid, as listed by the U.S. FDA as HPHCs of concern for e-cigarettes53,54. These compounds were not analysed in cigarette smoke because the Ky1R6F cigarette used in the study is an unflavoured US-blended cigarette and validated analytical methods for these compounds were not available.
All compounds were < LOD or < LOQ except for isoamyl acetate (isopentyl acetate) in the e-cigarette emissions (Table 5). This flavouring compound was used in both e-liquid formulations (BB57 and BB18), and therefore its presence in the e-cigarette emissions was expected. In a quantitative risk estimation performed in line with a published approach to the risk assessment of flavours in e-liquids100, the level of isoamyl acetate in the formulation was found to be supportable even if 100% of it were transferred to the aerosol. To further establish the level of risk, we again assumed a worst-case exposure of 300 puffs day–1 over 8 h77, which would result in isoamyl acetate exposure levels of 0.23 mg day–1 or 0.034 mg m–3. This is several orders of magnitude below various occupational exposure guidelines for isoamyl acetate, the lowest of which is 250 mg m–3, and below the acceptable daily intake of 3 mg kg–1 day–1 (180 mg day–1 for a 60-kg adult) established by the Joint FAO/WHO Expert Committee on Food Additives101,102.
The aim of this study was to undertake an assessment of the emissions generated by an e-cigarette using a ceramic wick-based technology and the comparison with conventional cigarette smoke. The generation of emissions from the e-cigarettes followed ISO 20768:2018 (55 mL puff volume, 3 s puff duration, 30 s puff frequency)52. ISO 20768:2018 lays out the essential requirements/conditions necessary to generate and collect e-cigarette emissions for analytical and comparison purposes in a robust and reproducible manner. The standard was developed building on the CORESTA (Cooperation Centre for Scientific Research Relative to Tobacco) recommended method no. 81 for machine puffing of e-cigarettes45,103. It is recognised that no single puffing regime can reflect the wide range of consumers’ puffing behaviour expected with e-cigarette use however, the use of ISO 20768:2018 is important for cross-product comparative purposes45. The application of different types of regime and its impact on the device performance is out of scope of this study. Nevertheless, the applied ISO standard puffing regime demonstrated that the emissions collected as block of 50 sequential puffs contained low levels of carbonyl compounds which would be associated with the thermal degradation of PG and VG. The carbonyl levels from the studied e-cigarettes emissions were either below the LOD or LOQ, or below the threshold levels proposed by the AFNOR standard guidelines, which provides evidence of the adequate wicking rate of the ceramic block without extreme coil heating under the test conditions. Whilst data generated from the first 50 puffs may not represent yields over the range of all puffs, especially as the liquid becomes depleted, the data are representative to enable generalised comparisons.
To follow a strategy of tobacco harm reduction, it is important to continually characterise the vapour emitted by newly developed e-cigarette devices relative to the smoke from combusted cigarettes in order to understand the chemical composition of the emissions. In this study, the focus was on the quantification of a wide range of HPHCs in the combustible cigarette smoke and the e-cigarette vapour emissions from the new pod/cartridge generation e-cigarettes using a ceramic-wick based technology. The higher nicotine emissions for BB57 compared with BB18 were not associated with a notable increase in the amounts of any of the quantified HPHCs. A substantial reduction of the levels of studied HPHCs and the nine TobReg priority smoke toxicants in the e-cigarette emissions relative to Ky1R6F combustible cigarette smoke was observed, with percentage of reductions in the range from 81.6% to > 99.9%. The low or undetectable levels of these compounds in e-cigarette emissions may be attributed to (1) the low operating temperature (< 350 °C) of the device; (2) an efficient supply of e-liquid by the ceramic wick to the heating coil without overheating of the coil or e-liquid; and (3) the use of pharmaceutical- or food-grade e-liquid ingredients. While the e-cigarette tested is unlikely to be risk-free, the results demonstrate that this ceramic wick-based device can offer considerably lower toxicant exposure when compared with combustible cigarettes under the tested conditions used in the study. Further pre-clinical in vitro, clinical and population studies are needed to evaluate the exposure of those toxicants and associated risks at an individual and populational level.
The e-cigarette device (Vype ePod1.0, Nicoventures Trading Ltd., Blackburn, UK) consists of a metallic outer device case, a printed circuit board to control the device, a lithium-ion rechargeable battery (350 mAh) and an e-cigarette cartridge (Fig. 1). The voltage ranges from 2.2 to 3.1 V and is not adjustable by the user. The device has dimensions (h × w × d) of 104.2 × 19.1 × 10.5 mm and a power output of 6.5 ± 0.5 W. The electronic parts are switched on when a puff is taken. The cartridges or pods consist of a plastic case holding the ceramic wick material and a flat metal heating element (NiCr, 0.8 –1.4-Ω resistance). Each pod is pre-filled with Vype e-liquid (1.9 mL) and is magnetically attached to the device.
The two e-liquids tested in the study were Berry Blast flavour with nicotine levels of 57 and 18 mg mL–1. Both e-liquids contained equivalent amounts of VG and PG (50:50, %w/w). Berry Blast 57 mg mL–1 (BB57) contained lactic acid, while Berry Blast 18 mg mL–1 (BB18) contained benzoic acid.
Ky1R6F reference standard cigarettes
The tobacco cigarette used as a comparator was the Kentucky Reference Cigarette 1R6F (Centre for Tobacco Reference Products, University of Kentucky, USA), which has been designed to provide a standard test piece for scientific studies. It is an unflavoured US-blended king-sized product with a cellulose acetate filter, an aerosol nicotine level of 1.9 ± 0.1 mg cig–1, and a tar yield of 29 ± 2 mg cig−1 as measured by the ISO Intense smoking regime6,56. At present, reference products for e-cigarette testing are not available.
Sample generation—smoking and puffing conditions
Sample generation and emissions testing were conducted by Labstat International ULC (Labstat, Kitchener, Ontario, Canada). Cigarettes were conditioned at a temperature of 22 ± 2 °C and a relative humidity of 60 ± 3% for at least 48 h as per ISO 3402104. Prior to testing, the reference Ky1R6F cigarettes were marked with the standard butt length specified by ISO 4387105. Smoking and puffing parameters and smoking machine specifications are summarized in Table 6.
Cigarettes were smoked under the ISO intense smoking regime to the butt mark with filter ventilation blocked (typically 9–10 puffs)40,57,106. E-cigarettes were puffed according to ISO 20768:201852. Smoking of cigarettes and puffing of e-cigarettes were carried out in dedicated conditioned rooms104 using either a rotary or a linear smoking machine52,57,106. Cigarette smoke and e-cigarette emissions were sampled/analysed as five independent replicates.
The analytical methods used by Labstat International ULC (Labstat, Kitchener, Ontario, Canada) are described in Supplementary Information, Table S1. In total, 23 different analytical methods were used to quantify 89 target analytes in the emissions from e-cigarettes and/or in mainstream Ky1R6F cigarette smoke. The methods used were largely based on Health Canada methods for cigarette smoke analysis, with additional methods developed by Labstat for other HPHCs and e-cigarette compounds of interest6. The methods were adapted for use with e-cigarettes where necessary. The operation of the methods is accredited to ISO/IEC 17025:2017107 for all reported constituents of mainstream tobacco smoke and e-cigarette aerosols, except where noted in Supplementary Table S1. Air (method) blank determinations were also conducted for e-cigarette emissions in order to identify background contaminants or other interference. The method LODs and LOQs are summarised in the Supplementary Information, Table S2.
Data analysis—percentage reduction
The percentage reduction in e-cigarette emissions was calculated relative to the Ky1R6F reference cigarette. For this calculation, the average of 5 replicate measurements for each product was used. For some toxicants, the level in the e-cigarette emissions was < LOD and/or < LOQ. In cases where the emissions were < LOD, the imputed value was LOD/26,107. For data < LOQ but > LOD, the imputed value was calculated as the midpoint between the reported LOD and LOQ6,108. Imputation was carried out on an individual replicate bases prior to calculating averages. In cases where both the e-cigarette and the reference combustible cigarette (Ky1R6F) emission levels were < LOQ or < LOD, the percentage reduction was not calculated (NC). LOD and LOQ for each compound for the e-cigarette emissions and cigarette smoke are reported in Supplementary Table S2.
Data are available from the authors on request. Any inquiries can be directed to the corresponding author.
Murphy, J. et al. Assessing modified risk tobacco and nicotine products: Description of the scientific framework and assessment of a closed modular electronic cigarette. Regul. Toxicol. Pharmacol. 90, 342–357 (2017).
Strongin, R. M. E-cigarette chemistry and analytical detection. Annu. Rev. Anal. Chem. 12, 23–39 (2019).
Williams, M. & Talbot, P. Design features in multiple generations of electronic cigarette atomizers. Int. J. Environ. Res. Public Health 16, 2904. https://doi.org/10.3390/ijerph16162904 (2019).
Breland, A. et al. Electronic cigarettes: What are they and what do they do?. Ann. N. Y. Acad. Sci. 1394, 5–30 (2017).
Brown, C. J. & Cheng, J. M. Electronic cigarettes: Product characterisation and design considerations. Tob. Control 23, ii4–ii10 (2014).
Margham, J. et al. Chemical composition of aerosol from an e-cigarette: A quantitative comparison with cigarette smoke. Chem. Res. Toxicol. 29, 1662–1678 (2016).
Huang, J. et al. Vaping versus JUULing: How the extraordinary growth and marketing of JUUL transformed the US retail e-cigarette market. Tob. Control 28, 146–151 (2019).
Romberg, A. R. et al. Patterns of nicotine concentrations in electronic cigarettes sold in the United States, 2013–2018. Drug Alcohol Depend. 203, 1–7 (2019).
Nicol, J. et al. Comprehensive chemical characterization of the aerosol emissions of a vaping product based on a new technology. Chem. Res. Toxicol. 33, 789–799 (2020).
Vreeke, S. et al. Dihydroxyacetone levels in electronic cigarettes: Wick temperature and toxin formation. Aerosol. Sci. Technol. 52, 370–376 (2018).
Gillman, I. G., Kistler, K. A., Stewart, E. W. & Paolantonio, A. R. Effect of variable power levels on the yield of total aerosol mass and formation of aldehydes in e-cigarette aerosols. Regul. Toxicol. Pharmacol. 75, 58–65 (2016).
Beyhaghi, S., Geoffroy, S., Prat, M. & Pillai, K. M. Wicking and evaporation of liquids in porous wicks: A simple analytical approach to optimization of wick design. AIChE J. 60, 1930–1940 (2014).
Vreeke, S., Zhu, X. & Strongin, R. M. A simple predictive model for estimating relative e-cigarette toxic carbonyl levels. PLoS ONE 15, e0238172. https://doi.org/10.1371/journal.pone.0238172 (2020).
Zhu, X. Ceramic heating elements for electronic cigarettes. United States patent US009763477B2 (2017).
Ward, A. M., Yaman, R. & Ebbert, J. O. Electronic nicotine delivery system design and aerosol toxicants: A systematic review. PLoS ONE 15, e0234189. https://doi.org/10.1371/journal.pone.0234189 (2020).
LaMothe, A. J. Device and method for vaporizing a fluid. United States patent US2017/0295848 A1 (2017).
Stephens, W. E., de Falco, B. & Fiore, A. A strategy for efficiently collecting aerosol condensate using silica fibers: Application to carbonyl emissions from e-cigarettes. Chem. Res. Toxicol. 32, 2053–2062 (2019).
Zhiping, C. Electronic cigarette and atomizing assembly and atomizing element thereof. United States patent US2017/0112193 A1 (2017).
Li, Y., Xu, Z., Dai, C. & Zou, X. Atomizer and electronic cigarette having same. United States patent US2017/0119060 A1 (2017).
Davis, M. F. et al. Microtextured liquid transport element for aerosol delivery device. United States patent application 15/679849 (2019).
DeVito, E. E. & Krishnan-Sarin, S. E-cigarettes: Impact of e-liquid components and device characteristics on nicotine exposure. Curr. Neuropharmacol. 16, 438–459 (2018).
Hajek, P., Przulj, D., Phillips, A., Anderson, R. & McRobbie, H. Nicotine delivery to users from cigarettes and from different types of e-cigarettes. Psychopharmacology 234, 773–779 (2017).
Teichert, A. et al. Evaluation of nicotine pharmacokinetics and subjective effects following use of a novel nicotine delivery system. Nicotine Tob. Res. 20, 458–465 (2018).
Bowen, A. & Xing, C. Nicotine salt formulations for aerosol devices and methods thereof. United Sates patent US2015/0020824 A1 (2015).
Harvanko, A. M., Havel, C. M., Jacob, P. & Benowitz, N. L. Characterization of nicotine salts in 23 electronic cigarette refill liquids. Nicotine Tob. Res. 22, 1239–1243 (2019).
O’Connell, G. et al. A randomised, open-label, cross-over clinical study to evaluate the pharmacokinetic profiles of cigarettes and e-cigarettes with nicotine salt formulations in US adult smokers. Intern. Emerg. Med. 14, 853–861 (2019).
Rose, J. E., Turner, J. E., Murugesan, T., Behm, F. M. & Laugesen, M. Pulmonary delivery of nicotine pyruvate: Sensory and pharmacokinetic characteristics. Exp. Clin. Psychopharmacol. 18, 385–394 (2010).
Ballesteros, D., Kuo, M. C., Song, Y. & Bueche, B. Aerosol formulation comprising nicotine salts. Patent Coorporation Treat PCT/WO2006/004646 A1 (2006).
Caldwell, B., Sumner, W. & Crane, J. A systematic review of nicotine by inhalation: Is there a role for the inhaled route?. Nicotine Tob. Res. 14, 1127–1139 (2012).
Britton, J. & Bogdanovica, I. Electronic Cigarettes: A Report Commissioned by Public Health England (Public Health England, 2014).
Mallock, N. et al. Trendy e-cigarettes enter Europe: Chemical characterization of JUUL pods and its aerosols. Arch. Toxicol. 94, 1985–1994 (2020).
Gholap, V. V., Heyder, R. S., Kosmider, L. & Halquist, M. S. An analytical perspective on determination of free base nicotine in e-Liquids. J. Anal. Methods Chem. 2020, 6178570. https://doi.org/10.1155/2020/6178570 (2020).
Misra, M., Leverette, R. D., Cooper, B. T., Bennett, M. B. & Brown, S. E. Comparative in vitro toxicity profile of electronic and tobacco cigarettes, smokeless tobacco and nicotine replacement therapy products: E-liquids, extracts and collected aerosols. Int. J. Environ. Res. Public Health 11, 11325–11347 (2014).
Wagner, K. A. et al. An evaluation of electronic cigarette formulations and aerosols for harmful and potentially harmful constituents (HPHCs) typically derived from combustion. Regul. Toxicol. Pharmacol. 95, 153–160 (2018).
Round, E. K., Chen, P., Taylor, A. K. & Schmidt, E. Biomarkers of tobacco exposure decrease after smokers switch to an e-cigarette or nicotine gum. Nicotine Tob. Res. 21, 1239–1247 (2019).
Tayyarah, R. & Long, G. A. Comparison of select analytes in aerosol from e-cigarettes with smoke from conventional cigarettes and with ambient air. Regul. Toxicol. Pharmacol. 70, 704–710 (2014).
Rudd, K. et al. Chemical composition and in vitro toxicity profile of a pod-based e-cigarette aerosol compared to cigarette smoke. Appl. In Vitro Toxicol. 6, 11–41 (2020).
Food and Drug Administration. Harmful and potentially harmful constituents (HPHCs). https://www.fda.gov/tobacco-products/products-ingredients-components/harmful-and-potentially-harmful-constituents-hphcs (2019).
Food and Drug Administration. Harmful and potentially harmful constituents in tobacco products and tobacco smoke; Established list. Department of Health and Human Services, Federal Register Vol. 77, 20034–20037 (2012).
Azzopardi, D. et al. Electronic cigarette aerosol induces significantly less cytotoxicity than tobacco smoke. Toxicol. Mech. Methods 26, 477–491 (2016).
Jaccard, G. et al. Comparative assessment of HPHC yields in the Tobacco Heating System THS2.2 and commercial cigarettes. Regul. Toxicol. Pharmacol. 90, 1–8 (2017).
McNeill, A., Brose, L. S., Calder, R., Bauld, L. & Robson, D. Evidence Review of e-Cigarettes and Heated Tobacco Products 2018. A Report Commissioned by Public Health England (Public Health England, 2018).
McNeill, A. et al. E-cigarettes: An Evidence Update. A Report Commissioned by Public Health England (Public Health England, 2015).
WHO Study Group on Tobacco Product Regulation. Report on the scientific basis of tobacco product regulation: seventh report of a WHO study group. WHO Technical Report Series, No. 1015 (World Health Organization, 2019).
Boué, S. et al. State-of-the-art methods and devices for the generation, exposure, and collection of aerosols from heat-not-burn tobacco products. Toxicol. Res. Applic. 4, 1–40 (2020).
Filippidis, F. T., Laverty, A. A. & Vardavas, C. I. Experimentation with e-cigarettes as a smoking cessation aid: A cross-sectional study in 28 European Union member states. BMJ Open 6, e012084. https://doi.org/10.1136/bmjopen-2016-012084 (2016).
Cirillo, S. et al. Impact of electronic cigarette heating coil resistance on the production of reactive carbonyls, reactive oxygen species and induction of cytotoxicity in human lung cancer cells in vitro. Regul. Toxicol. Pharmacol. 109, 104500. https://doi.org/10.1016/j.yrtph.2019.104500 (2019).
El-Hellani, A. et al. Nicotine and carbonyl emissions from popular electronic cigarette products: Correlation to liquid composition and design characteristics. Nicotine Tob. Res. 20, 215–223. https://doi.org/10.1093/ntr/ntw280 (2018).
Sleiman, M. et al. Emissions from electronic cigarettes: Key parameters affecting the release of harmful chemicals. Environ. Sci. Technol. 50, 9644–9651 (2016).
Hutzler, C. et al. Chemical hazards present in liquids and vapors of electronic cigarettes. Arch. Toxicol. 88, 1295–1308 (2014).
Salamanca, J. C. et al. E-cigarettes can emit formaldehyde at high levels under conditions that have been reported to be non-averse to users. Sci. Rep. 8, 7559. https://doi.org/10.1038/s41598-018-25907-6 (2018).
ISO. Vapour products—routine analytical vaping machine—Definitions and standard conditions. ISO20768:2018 (International Organization for Standardization, 2018).
Food and Drug Administration. Premarket Tobacco Product Applications for Electronic Nicotine Delivery Systems: Guidance for Industry (US Department of Health and Human Services, 2019).
Food and Drug Administration. Harmful and potentially harmful constituents in tobacco products and tobacco smoke; Established list; Proposed additions; Request for comments. Department of Health and Human Services, Federal Register Vol. 84, 38032–38035 (2019).
Burns, D. M. et al. Mandated lowering of toxicants in cigarette smoke: A description of the World Health Organization TobReg proposal. Tob. Control 17, 132–141 (2008).
University of Kentucky. Certificate of Analysis—1R6F Certificate Reference Cigarette. https://ctrp.uky.edu/products/gallery/Reference%20Cigarettes/detail/937 (2018).
ISO. Cigarettes—Routine analytical cigarette smoking machine—Definitions and standard conditions with an intense smoking regime. ISO20778:2018 (International Organization for Standardization, 2018).
Ghosh, D. & Jeannet, C. An improved Cambridge filter pad extraction methodology to obtain more accurate water and “tar” values: In situ Cambridge filter pad extraction methodology. Beitr. Tabakforsch. Int. 26, 38–49 (2014).
United States Pharmacopeia. Glycerin Monograph (United States Pharmacopeial Convention, 2009).
Molever, K. Simplified assay of diethylene glycol and ethylene glycol in various raw materials by capillary gas chromatography. J. Cosmet. Sci. 61, 225–234 (2010).
Burstyn, I. Peering through the mist: Systematic review of what the chemistry of contaminants in electronic cigarettes tells us about health risks. BMC Public Health 14, 18. https://doi.org/10.1186/1471-2458-14-18 (2014).
United States Pharmacopeia. Propylene Glycol Monograph (United States Pharmacopeial Convention, 2010).
International Agency of Research on Cancer. In Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 77, 469, (IARC, 2000).
National Academies of Sciences, Engineering, and Medicine. In Public Health Consequences of E-Cigarettes (eds Eaton, D. L. et al.) (National Academies Press, 2018).
Liu, X., Joza, P. & Rickert, B. Analysis of nicotine and nicotine-related compounds in electronic cigarette liquids and aerosols by liquid chromatography–tandem mass spectrometry. Beitr. Tabakforsch. Int. 27, 154–167 (2017).
Flora, J. W., Wilkinson, C. T., Sink, K. M., McKinney, D. L. & Miller, J. H. Nicotine-related impurities in e-cigarette cartridges and refill e-liquids. J. Liquid Chromatogr. Relat. Technol. 39, 821–829 (2017).
Flora, J. W. et al. Characterization of potential impurities and degradation products in electronic cigarette formulations and aerosols. Regul. Toxicol. Pharmacol 74, 1–11 (2016).
European Pharmacopoeia. Nicotine. Monograph 1452. Ph. Eur. 10.2 update (EDQM, 2020).
Clayton, P., Lu, A. & Bishop, L. The pyrolysis of (–)-(S)-nicotine: Racemization and decomposition. Chirality 22, 442–446 (2010).
Famele, M. et al. The chemical components of electronic cigarette cartridges and refill fluids: Review of analytical methods. Nicotine Tob. Res. 17, 271–279 (2015).
Farsalinos, K. E. et al. Nicotine levels and presence of selected tobacco-derived toxins in tobacco flavoured electronic cigarette refill liquids. Int. J. Environ. Res. Public Health 12, 3439–3452 (2015).
Rodgman, A. & Perfetti, T. A. (eds) The Chemical Components of Tobacco and Tobacco Smoke 2nd edn. (CRC Press, 2013).
Konstantinou, E. et al. Tobacco-specific nitrosamines: A literature review. Food Chem. Toxicol. 118, 198–203 (2018).
Davis, D. L. & Nielson, M. T. (eds) Tobacco: Production, Chemistry and Technology (Blackwell Science Ltd, 1999).
Edwards, S. H. et al. Tobacco-specific nitrosamines in the tobacco and mainstream smoke of US commercial cigarettes. Chem. Res. Toxicol 30, 540–551 (2017).
Vu, A. T. et al. Polycyclic Aromatic hydrocarbons in the mainstream smoke of popular US cigarettes. Chem. Res. Toxicol 28, 1616–1626 (2015).
Dautzenberg, B. Real-time characterization of e-cigarettes use: The 1 million puffs study. J. Addict. Res. Ther. 6, 229 (2015).
Kroes, R. et al. Structure-based thresholds of toxicological concern (TTC): Guidance for application to substances present at low levels in the diet. Food Chem. Toxicol. 42, 65–83 (2004).
Committee on Mutagenicity. Interim guidance for a strategy on genotoxicity testing and mutagenic hazard assessment of impurities in chemical substances. COM/12/ S2 (Committee on Mutagenicity of Chemicals in Food, Consumer Products and the Environment, 2012).
Dagnon, S., Stoilova, A., Ivanov, I. & Nikolova, S. The effect of cigarette design on the content of phenols in mainstream tobacco smoke. Beitr. Tabakforsch. Int. 24, 187–193 (2011).
Sepetdjian, E. et al. Phenolic compounds in particles of mainstream waterpipe smoke. Nicotine Tob. Res. 15, 1107–1112 (2013).
El-Hage, R. et al. Vaped humectants in e-cigarettes are a source of phenols. Chem. Res. Toxicol 33, 2374–2380 (2020).
Farsalinos, K. E. & Gillman, G. Carbonyl emissions in e-cigarette aerosol: A systematic review and methodological considerations. Front Physiol 8, 1119 (2018).
Ooi, B. G., Dutta, D., Kazipeta, K. & Chong, N. S. Influence of the e-cigarette emission profile by the ratio of glycerol to propylene glycol in e-liquid composition. ACS Omega 4, 13338–13348 (2019).
Uchiyama, S. et al. Determination of thermal decomposition products generated from e-cigarettes. Chem. Res. Toxicol 33, 576–583 (2020).
Son, Y., Bhattarai, C., Samburova, V. & Khlystov, A. Carbonyls and carbon monoxide emissions from electronic cigarettes affected by device type and use patterns. Int. J. Environ. Res. Public Health 17, 2767 (2020).
Bekki, K. et al. Carbonyl compounds generated from electronic cigarettes. Int. J. Environ. Res. Public Health 11, 11192–11200 (2014).
Munzel, T. et al. Effects of tobacco cigarettes, e-cigarettes, and waterpipe smoking on endothelial function and clinical outcomes. Eur Heart J 41, 4057–4070 (2020).
Beauval, N. et al. Influence of puffing conditions on the carbonyl composition of e-cigarette aerosols. Int. J. Hyg. Environ. Health 222, 136–146 (2019).
Belushkin, M. et al. Selected harmful and potentially harmful constituents levels in commercial e-cigarettes. Chem. Res. Toxicol. 33, 657–668 (2020).
AFNOR. Electronic cigarettes and e liquids: Part 3—Requirements and test methods for emissions. XP D90-300-3 (Association Française de Normalisation, 2016).
Margham, J. et al. The chemical complexity of e-cigarettes aerosol compared with the smoke from a tobacco burning cigarette. Front. Chem. 9, 743060 (2021).
Vas, C. A., Porter, A. & McAdam, K. Acetoin is a precursor to diacetyl in e-cigarette liquids. Food Chem. Toxicol. 133, 110727 (2019).
Occupational Safety and Health Administration. Glyoxal. https://www.osha.gov/chemicaldata/chemResult.html?RecNo=64 (2018).
The National Institute for Occupational Safety and Health. Glyoxal, 40%. https://www.cdc.gov/niosh-rtecs/MD2932E0.html (2018).
Bao, M., Joza, P. J., Masters, A. & Rickert, W. S. Analysis of selected carbonyl compounds in tobacco samples by using pentafluorobenzylhydroxylamine derivatization and gas chromatography–mass spectrometry. Beitr. Tabakforsch. Int. 26, 86–97 (2014).
Uchiyama, S., Inaba, Y. & Kunugita, N. Derivatization of carbonyl compounds with 2,4-dinitrophenylhydrazine and their subsequent determination by high-performance liquid chromatography. J. Chromatogr. B Sci. 879, 1282–1289 (2011).
Pankow, J. F. et al. Benzene formation in electronic cigarettes. PLoS ONE 12, e0173055 (2017).
Jensen, R. P. Thermal decomposition of electronic cigarette liquids. PhD Thesis (Portland State University, 2016).
Costigan, S. & Meredith, C. An approach to ingredient screening and toxicological risk assessment of flavours in e-liquids. Regul. Toxicol. Pharmacol. 72, 361–369 (2015).
Institut für Arbeitsschutz der Deutschen Gesetzlichen Unfallversicherung. Isopentyl acetate. https://limitvalue.ifa.dguv.de/ (2020).
Joint FAO/WHO Expert Committee on Food additives. Isoamyl acetate. https://apps.who.int/food-additives-contaminants-jecfa-database/chemical.aspx?chemID=174 (2019).
CORESTA. Routine analytical machine for e-cigarettes aerosol generation and collection—Definitions and standard conditions. CRM 81 (CORESTA, 2015).
ISO. Tobacco and tobacco products—Atmosphere for conditioning and testing, ISO3402:1999 (International Organization for Standardization, 1999).
ISO. Cigarettes—Determination of total and nicotine-free dry particulate matter using a routine analytical smoking machine. ISO4387:2000. (International Organization for Standardization, 2000).
ISO. Routine analytical cigarette smoking machine—Definitions and standard conditions. ISO3308:2012. (International Organization for Standardization, 2012).
ISO. General requirements for the competence of testing and calibration laboratories. ISO/IEC 17025:2017 (International Organization for Standardization, 2017).
Forster, M. et al. Assessment of novel tobacco heating product THP1.0. Part 3: Comprehensive chemical characterisation of harmful and potentially harmful aerosol emissions. Regul. Toxicol. Pharmacol. 93, 14–33 (2018).
We acknowledge the assistance of Belinda Zonnestein in sourcing and testing of the products. We further acknowledge My-Linh Tran and Joseph Sutton for their contribution to product development and provision of product details and to Sandra Costigan and Elaine Brown for the toxicological inputs.
B.A.T (Investments) was the funding organization for the study. All authors were employed by BAT.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Pinto, M.I., Thissen, J., Hermes, N. et al. Chemical characterisation of the vapour emitted by an e-cigarette using a ceramic wick-based technology. Sci Rep 12, 16497 (2022). https://doi.org/10.1038/s41598-022-19761-w
This article is cited by
Biomarkers of exposure and potential harm in exclusive users of electronic cigarettes and current, former, and never smokers
Internal and Emergency Medicine (2023)